Karin Jooss - Net Worth and Insider Trading
Karin Jooss Net Worth
The estimated net worth of Karin Jooss is at least $20,497 dollars as of 2024-11-05. Karin Jooss is the SEE REMARKS of Gritstone Bio Inc and owns about 683,526 shares of Gritstone Bio Inc (GRTSQ) stock worth over $17,430. Karin Jooss is also the Director of Fate Therapeutics Inc and owns about 1,198 shares of Fate Therapeutics Inc (FATE) stock worth over $3,067. Details can be seen in Karin Jooss's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karin Jooss has not made any transactions after 2024-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karin Jooss
Karin Jooss Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karin Jooss owns 2 companies in total, including Fate Therapeutics Inc (FATE) , and Gritstone Bio Inc (GRTSQ) .
Click here to see the complete history of Karin Jooss’s form 4 insider trades.
Insider Ownership Summary of Karin Jooss
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FATE | Fate Therapeutics Inc | 2022-06-03 | director |
| GRTSQ | Gritstone Bio Inc | 2024-05-16 | See Remarks |
Karin Jooss Latest Holdings Summary
Karin Jooss currently owns a total of 2 stocks. Among these stocks, Karin Jooss owns 683,526 shares of Gritstone Bio Inc (GRTSQ) as of May 16, 2024, with a value of $17,430 and a weighting of 85.04%. Karin Jooss also owns 1,198 shares of Fate Therapeutics Inc (FATE) as of June 3, 2022, with a value of $3,067 and a weighting of 14.96%.
Latest Holdings of Karin Jooss
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GRTSQ | Gritstone Bio Inc | 2024-05-16 | 683,526 | 0.03 | 17,430 |
| FATE | Fate Therapeutics Inc | 2022-06-03 | 1,198 | 2.56 | 3,067 |
Holding Weightings of Karin Jooss
Karin Jooss Form 4 Trading Tracker
According to the SEC Form 4 filings, Karin Jooss has made a total of 1 transactions in Gritstone Bio Inc (GRTSQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Gritstone Bio Inc is the sale of 13,749 shares on May 16, 2024, which brought Karin Jooss around $10,312.
According to the SEC Form 4 filings, Karin Jooss has made a total of 1 transactions in Fate Therapeutics Inc (FATE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Fate Therapeutics Inc is the sale of 1,483 shares on June 3, 2022, which brought Karin Jooss around $33,842.
Insider Trading History of Karin Jooss
- 1
Karin Jooss Trading Performance
Karin Jooss Ownership Network
Ownership Network List of Karin Jooss
Ownership Network Relation of Karin Jooss
Karin Jooss Owned Company Details
What does Fate Therapeutics Inc do?
Who are the key executives at Fate Therapeutics Inc?
Karin Jooss is the director of Fate Therapeutics Inc. Other key executives at Fate Therapeutics Inc include Chief Financial Officer Dulac Edward J Iii , director & President and CEO J Scott Wolchko , and Chief Development Officer Bahram Valamehr .
Fate Therapeutics Inc (FATE) Insider Trades Summary
Over the past 18 months, Karin Jooss made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 18,777 shares made by Dulac Edward J Iii , a net sale of 4,725 shares made by Yuan Xu , and a net sale of 35,237 shares made by Cindy Tahl .
In summary, during the past 3 months, insiders sold 633 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 633 shares. During the past 18 months, 88,255 shares of Fate Therapeutics Inc (FATE) were sold and 44,630 shares were bought by its insiders, resulting in a net sale of 43,625 shares.
Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fate Therapeutics Inc Insider Transactions
Karin Jooss Mailing Address
Above is the net worth, insider trading, and ownership report for Karin Jooss. You might contact Karin Jooss via mailing address: C/o Gritstone Oncology, Inc., 5858 Horton Street, Suite 210, Emeryville Ca 94608.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
